Predicine is a global molecular insights company that is committed to advancing precision medicine in oncology. Predicine has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. The company has launched a portfolio of blood-, urine- and tissue-based diagnostic assays for oncology. Through its business operations in Silicon Valley, Houston, Shanghai, Singapore, and Boston, Predicine partners with leading biopharma companies, institutions and governments to support personalized healthcare on a global scale.
Company Details
- Employees
- 99
- Founded
- -
- Address
- 3555 Arden Road, Hayward,ca 94545,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.predicine.com
- Keywords
- precision medicine, non-invasive cancer diagnostics, precision diagnostics, biomarker, liquid biopsy, clinical trial, COVID-19, oncology, infectious diseases, MRD.
- HQ
- Hayward, CA
Predicine Questions
Predicine's website is http://www.predicine.com
Predicine's LinkedIn profile is https://www.linkedin.com/company/predicine
Predicine has
99 employees.
View email and phone details for 99
employees at Predicine.
Predicine's industry is
Biotechnology Research
Predicine's top competitors are
Guardant Health,
Natera,
Genentech,
Billiontoone,
Freenome,
Personalis, Inc.,
Invitae,
Myriad Genetics,
Revolution Medicines,
Alamar Biosciences, Inc..
Predicine's categories are Biotechnology Research
Predicine's founding year is 2015
